Landscape of human antibody recognition of the SARS-CoV-2 receptor binding domainAdam K. Wheatley, Wai‐Hong Tham, Hannah G. Kelly et al.|Cell Reports|2021Cited by 80
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responsesVeronica Zoest, Hyon‐Xhi Tan, Wen Shi Lee et al.|bioRxiv (Cold Spring Harbor Laboratory)|2025Cited by 1
A novel chimeric coronavirus spike vaccine combining SARS-CoV-2 RBD and scaffold domains from HKU-1 elicits potent neutralising antibody responsesVeronica Zoest, Hyon‐Xhi Tan, Wen Shi Lee et al.|npj Vaccines|2025Cited by 1